Global Live Biotherapeutic Products And Microbiome CDMO Market Size, Share & Industry Trends Analysis Report By Application (C.difficile, Crohns Disease, IBS, Diabetes, and Others), By Regional Outlook and Forecast, 2023 - 2029
Published Date : 31-May-2023 |
Pages: 128 |
Formats: PDF |
COVID-19 Impact on the Live Biotherapeutic Products And Microbiome CDMO Market
Market Overview
The Global Live Biotherapeutic Products And Microbiome CDMO Market size is expected to reach $159.1 million by 2029, rising at a market growth of 42.5% CAGR during the forecast period.
Diabetes is one of the major applications of live biotherapeutic products and microbiome CDMO market and captured more than 35% share in the market during 2022 as it is recognized as one of the most important unaddressed worldwide health problems. It poses a significant risk for several prevalent, occasionally fatal conditions like hypertension, coronary heart disease, stroke, kidney failure, and retinopathy. According to WHO, approximately 2 million people died in 2019 from diabetes-related renal damage. A total of 1.5 million deaths were directly related to diabetes in 2019, and 48% of these deaths occurred in those under the age of 70. Diabetes contributed to an additional 460 000 renal disease fatalities, and elevated blood glucose is responsible for almost 20% of cardiovascular mortality. Some of the factors impacting the market are increasing efforts to create novel treatments for different ailments, recent development in live biotherapeutic products that can modulate neurological diseases associated with the gut-brain axis, and lack of standards and infrastructure for developing LBPs.
During the COVID-19 outbreak, people were more concerned about contracting bacterial and viral diseases. The COVID-19 pandemic necessitated a significant reallocation of resources to be focused on the diagnostic, treatment, as well as vaccination efforts. Because of this, resources were diverted from the development of live biotherapeutic products and used in other healthcare fields instead. In addition, during the pandemic, there was a significant drop in consumer demand for LBPs, which had a detrimental impact on market growth.
The impact of increasing product demand globally is a crucial market phenomenon that has sparked the creation of novel medicinal remedies. The market is expected to see growth prospects throughout the projection period as a result of rising product demand and a major uptick in the microbiome and LBP therapies. There is currently no definitive treatment used routinely for autism. Among the treatments used are sensory integration, cognitive education, and physical therapy. New research suggests that treating autistic children by changing their gut microbiota may be effective.
However, it is difficult to exert any degree of control on the expansion of live microbes, either at the level of their production or during the remaining stages of their lifecycles. It is generally known that the quality of the raw materials (pharmaceutical grade and ideally free of substances derived from animals) and the manufacturing process (which includes the environmental conditions, production facility and equipment used) are important for LBP production. Additionally, the education of employees in hygiene & sanitation and the control procedures and quality monitoring are of utmost importance as well. Hence, all these elements may hamper the market's growth throughout the forecast period.
Application Outlook
Based on application, the live biotherapeutic products and microbiome CDMO market is characterized into C.difficile, Crohn’s disease, IBS, diabetes, and others. The C.difficile segment garnered the highest revenue share in the live biotherapeutic products and microbiome CDMO market in 2022. In particular, in patients who are currently using antibiotics, the bacterium C. difficile, which is present in the human gut microbiome, can cause serious diarrhea and colitis. As a result, live biotherapeutic products have attracted increasing attention in recent years due to their potential to cure a variety of illnesses, including those involving the gut microbiome.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 14 Million |
| Market size forecast in 2029 | USD 159.1 Million |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2029 |
| Revenue Growth Rate | CAGR of 42.5% from 2023 to 2029 |
| Number of Pages | 128 |
| Number of Table | 190 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Application, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Regional Outlook
Region wise, the live biotherapeutic products and microbiome CDMO market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the largest revenue share in the live biotherapeutic products and microbiome CDMO market in 2022. This rise is mostly attributable to the presence of important firms and rising investments in R&D activities in the region. However, the expansion of the market in North America has also been influenced by the rising demand for effective therapies for a variety of illnesses such as C. diff, Crohn's disease, and IBS.
Free Valuable Insights: Global Live Biotherapeutic Products And Microbiome CDMO Market size to reach USD 159.1 Million by 2029
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Arranta Bio Holdings, LLC (Recipharm AB) (EQT AB), Cerbios-Pharma SA, Biose Industrie, List Biological Laboratories, Inc., AcuraBio Pty Ltd (Ampersand Capital Partners), Wacker Chemie AG (Dr. Alexander Wacker Familiengesellschaft mbH), Quay Pharmaceuticals Ltd (SGS S.A.), BiomX, Inc., Lonza Group AG, and 4D Pharma Plc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- C.difficile
- Crohns Disease
- IBS
- Diabetes
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Arranta Bio Holdings, LLC (Recipharm AB) (EQT AB)
- Cerbios-Pharma SA
- Biose Industrie
- List Biological Laboratories, Inc.
- AcuraBio Pty Ltd (Ampersand Capital Partners)
- Wacker Chemie AG (Dr. Alexander Wacker Familiengesellschaft mbH)
- Quay Pharmaceuticals Ltd (SGS S.A.)
- BiomX, Inc.
- Lonza Group AG
- 4D Pharma Plc
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Live Biotherapeutic Products And Microbiome CDMO Market, by Application
1.4.2 Global Live Biotherapeutic Products And Microbiome CDMO Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Live Biotherapeutic Products And Microbiome CDMO Market by Application
3.1 Global C.difficile Market by Region
3.2 Global Crohns Disease Market by Region
3.3 Global IBS Market by Region
3.4 Global Diabetes Market by Region
3.5 Global Others Market by Region
Chapter 4. Global Live Biotherapeutic Products And Microbiome CDMO Market by Region
4.1 North America Live Biotherapeutic Products And Microbiome CDMO Market
4.1.1 North America Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.1.1.1 North America C.difficile Market by Country
4.1.1.2 North America Crohns Disease Market by Country
4.1.1.3 North America IBS Market by Country
4.1.1.4 North America Diabetes Market by Country
4.1.1.5 North America Others Market by Country
4.1.2 North America Live Biotherapeutic Products And Microbiome CDMO Market by Country
4.1.2.1 US Live Biotherapeutic Products And Microbiome CDMO Market
4.1.2.1.1 US Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.1.2.2 Canada Live Biotherapeutic Products And Microbiome CDMO Market
4.1.2.2.1 Canada Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.1.2.3 Mexico Live Biotherapeutic Products And Microbiome CDMO Market
4.1.2.3.1 Mexico Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.1.2.4 Rest of North America Live Biotherapeutic Products And Microbiome CDMO Market
4.1.2.4.1 Rest of North America Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2 Europe Live Biotherapeutic Products And Microbiome CDMO Market
4.2.1 Europe Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.1.1 Europe C.difficile Market by Country
4.2.1.2 Europe Crohns Disease Market by Country
4.2.1.3 Europe IBS Market by Country
4.2.1.4 Europe Diabetes Market by Country
4.2.1.5 Europe Others Market by Country
4.2.2 Europe Live Biotherapeutic Products And Microbiome CDMO Market by Country
4.2.2.1 Germany Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.1.1 Germany Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.2.2 UK Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.2.1 UK Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.2.3 France Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.3.1 France Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.2.4 Russia Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.4.1 Russia Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.2.5 Spain Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.5.1 Spain Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.2.6 Italy Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.6.1 Italy Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.2.7 Rest of Europe Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.7.1 Rest of Europe Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market
4.3.1 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.1.1 Asia Pacific C.difficile Market by Country
4.3.1.2 Asia Pacific Crohns Disease Market by Country
4.3.1.3 Asia Pacific IBS Market by Country
4.3.1.4 Asia Pacific Diabetes Market by Country
4.3.1.5 Asia Pacific Others Market by Country
4.3.2 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Country
4.3.2.1 China Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.1.1 China Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.2.2 Japan Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.2.1 Japan Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.2.3 India Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.3.1 India Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.2.4 South Korea Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.4.1 South Korea Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.2.5 Singapore Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.5.1 Singapore Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.2.6 Malaysia Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.6.1 Malaysia Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.2.7 Rest of Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.7.1 Rest of Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market
4.4.1 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.1.1 LAMEA C.difficile Market by Country
4.4.1.2 LAMEA Crohns Disease Market by Country
4.4.1.3 LAMEA IBS Market by Country
4.4.1.4 LAMEA Diabetes Market by Country
4.4.1.5 LAMEA Others Market by Country
4.4.2 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Country
4.4.2.1 Brazil Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.1.1 Brazil Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.2.2 Argentina Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.2.1 Argentina Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.2.3 UAE Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.3.1 UAE Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.2.4 Saudi Arabia Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.4.1 Saudi Arabia Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.2.5 South Africa Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.5.1 South Africa Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.2.6 Nigeria Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.6.1 Nigeria Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.2.7 Rest of LAMEA Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.7.1 Rest of LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Application
Chapter 5. Company Profiles
5.1 Arranta Bio Holdings, LLC (Recipharm AB) (EQT AB)
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Segmental and Regional Analysis
5.1.4 Recent strategies and developments:
5.1.4.1 Acquisition and Mergers:
5.1.4.2 Geographical Expansions:
5.2 Cerbios-Pharma SA
5.2.1 Company Overview
5.3 Biose Industrie
5.3.1 Company Overview
5.3.2 Recent strategies and developments:
5.3.2.1 Geographical Expansions:
5.4 List Biological Laboratories, Inc.
5.4.1 Company Overview
5.5 AcuraBio Pty Ltd (Ampersand Capital Partners)
5.5.1 Company Overview
5.6 Wacker Chemie AG (Dr. Alexander Wacker Familiengesellschaft mbH)
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expenses
5.7 Quay Pharmaceuticals Ltd (SGS S.A.)
5.7.1 Company Overview
5.7.2 Financial Analysis
5.7.3 Segmental Analysis
5.7.4 Recent strategies and developments:
5.7.4.1 Partnerships, Collaborations, and Agreements:
5.8 BiomX, Inc.
5.8.1 Company Overview
5.8.2 Research & Development Expenses
5.9 Lonza Group AG
5.9.1 Company Overview
5.9.2 Financial Analysis
5.9.3 Segmental and Regional Analysis
5.9.4 Research & Development Expenses
5.9.5 Recent strategies and developments:
5.9.5.1 Acquisition, Joint Ventures, and Mergers:
5.10. 4D Pharma Plc
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Research & Development Expense
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Live Biotherapeutic Products And Microbiome CDMO Market, by Application
1.4.2 Global Live Biotherapeutic Products And Microbiome CDMO Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Live Biotherapeutic Products And Microbiome CDMO Market by Application
3.1 Global C.difficile Market by Region
3.2 Global Crohns Disease Market by Region
3.3 Global IBS Market by Region
3.4 Global Diabetes Market by Region
3.5 Global Others Market by Region
Chapter 4. Global Live Biotherapeutic Products And Microbiome CDMO Market by Region
4.1 North America Live Biotherapeutic Products And Microbiome CDMO Market
4.1.1 North America Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.1.1.1 North America C.difficile Market by Country
4.1.1.2 North America Crohns Disease Market by Country
4.1.1.3 North America IBS Market by Country
4.1.1.4 North America Diabetes Market by Country
4.1.1.5 North America Others Market by Country
4.1.2 North America Live Biotherapeutic Products And Microbiome CDMO Market by Country
4.1.2.1 US Live Biotherapeutic Products And Microbiome CDMO Market
4.1.2.1.1 US Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.1.2.2 Canada Live Biotherapeutic Products And Microbiome CDMO Market
4.1.2.2.1 Canada Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.1.2.3 Mexico Live Biotherapeutic Products And Microbiome CDMO Market
4.1.2.3.1 Mexico Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.1.2.4 Rest of North America Live Biotherapeutic Products And Microbiome CDMO Market
4.1.2.4.1 Rest of North America Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2 Europe Live Biotherapeutic Products And Microbiome CDMO Market
4.2.1 Europe Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.1.1 Europe C.difficile Market by Country
4.2.1.2 Europe Crohns Disease Market by Country
4.2.1.3 Europe IBS Market by Country
4.2.1.4 Europe Diabetes Market by Country
4.2.1.5 Europe Others Market by Country
4.2.2 Europe Live Biotherapeutic Products And Microbiome CDMO Market by Country
4.2.2.1 Germany Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.1.1 Germany Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.2.2 UK Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.2.1 UK Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.2.3 France Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.3.1 France Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.2.4 Russia Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.4.1 Russia Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.2.5 Spain Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.5.1 Spain Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.2.6 Italy Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.6.1 Italy Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.2.2.7 Rest of Europe Live Biotherapeutic Products And Microbiome CDMO Market
4.2.2.7.1 Rest of Europe Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market
4.3.1 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.1.1 Asia Pacific C.difficile Market by Country
4.3.1.2 Asia Pacific Crohns Disease Market by Country
4.3.1.3 Asia Pacific IBS Market by Country
4.3.1.4 Asia Pacific Diabetes Market by Country
4.3.1.5 Asia Pacific Others Market by Country
4.3.2 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Country
4.3.2.1 China Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.1.1 China Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.2.2 Japan Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.2.1 Japan Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.2.3 India Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.3.1 India Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.2.4 South Korea Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.4.1 South Korea Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.2.5 Singapore Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.5.1 Singapore Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.2.6 Malaysia Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.6.1 Malaysia Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.3.2.7 Rest of Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market
4.3.2.7.1 Rest of Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market
4.4.1 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.1.1 LAMEA C.difficile Market by Country
4.4.1.2 LAMEA Crohns Disease Market by Country
4.4.1.3 LAMEA IBS Market by Country
4.4.1.4 LAMEA Diabetes Market by Country
4.4.1.5 LAMEA Others Market by Country
4.4.2 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Country
4.4.2.1 Brazil Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.1.1 Brazil Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.2.2 Argentina Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.2.1 Argentina Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.2.3 UAE Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.3.1 UAE Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.2.4 Saudi Arabia Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.4.1 Saudi Arabia Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.2.5 South Africa Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.5.1 South Africa Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.2.6 Nigeria Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.6.1 Nigeria Live Biotherapeutic Products And Microbiome CDMO Market by Application
4.4.2.7 Rest of LAMEA Live Biotherapeutic Products And Microbiome CDMO Market
4.4.2.7.1 Rest of LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Application
Chapter 5. Company Profiles
5.1 Arranta Bio Holdings, LLC (Recipharm AB) (EQT AB)
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Segmental and Regional Analysis
5.1.4 Recent strategies and developments:
5.1.4.1 Acquisition and Mergers:
5.1.4.2 Geographical Expansions:
5.2 Cerbios-Pharma SA
5.2.1 Company Overview
5.3 Biose Industrie
5.3.1 Company Overview
5.3.2 Recent strategies and developments:
5.3.2.1 Geographical Expansions:
5.4 List Biological Laboratories, Inc.
5.4.1 Company Overview
5.5 AcuraBio Pty Ltd (Ampersand Capital Partners)
5.5.1 Company Overview
5.6 Wacker Chemie AG (Dr. Alexander Wacker Familiengesellschaft mbH)
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expenses
5.7 Quay Pharmaceuticals Ltd (SGS S.A.)
5.7.1 Company Overview
5.7.2 Financial Analysis
5.7.3 Segmental Analysis
5.7.4 Recent strategies and developments:
5.7.4.1 Partnerships, Collaborations, and Agreements:
5.8 BiomX, Inc.
5.8.1 Company Overview
5.8.2 Research & Development Expenses
5.9 Lonza Group AG
5.9.1 Company Overview
5.9.2 Financial Analysis
5.9.3 Segmental and Regional Analysis
5.9.4 Research & Development Expenses
5.9.5 Recent strategies and developments:
5.9.5.1 Acquisition, Joint Ventures, and Mergers:
5.10. 4D Pharma Plc
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Research & Development Expense
List of Tables
TABLE 1 Global Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 2 Global Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 3 Global Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 4 Global Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 5 Global C.difficile Market by Region, 2019 - 2022, USD Thousands
TABLE 6 Global C.difficile Market by Region, 2023 - 2029, USD Thousands
TABLE 7 Global Crohns Disease Market by Region, 2019 - 2022, USD Thousands
TABLE 8 Global Crohns Disease Market by Region, 2023 - 2029, USD Thousands
TABLE 9 Global IBS Market by Region, 2019 - 2022, USD Thousands
TABLE 10 Global IBS Market by Region, 2023 - 2029, USD Thousands
TABLE 11 Global Diabetes Market by Region, 2019 - 2022, USD Thousands
TABLE 12 Global Diabetes Market by Region, 2023 - 2029, USD Thousands
TABLE 13 Global Others Market by Region, 2019 - 2022, USD Thousands
TABLE 14 Global Others Market by Region, 2023 - 2029, USD Thousands
TABLE 15 Global Live Biotherapeutic Products And Microbiome CDMO Market by Region, 2019 - 2022, USD Thousands
TABLE 16 Global Live Biotherapeutic Products And Microbiome CDMO Market by Region, 2023 - 2029, USD Thousands
TABLE 17 North America Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 18 North America Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 19 North America Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 20 North America Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 21 North America C.difficile Market by Country, 2019 - 2022, USD Thousands
TABLE 22 North America C.difficile Market by Country, 2023 - 2029, USD Thousands
TABLE 23 North America Crohns Disease Market by Country, 2019 - 2022, USD Thousands
TABLE 24 North America Crohns Disease Market by Country, 2023 - 2029, USD Thousands
TABLE 25 North America IBS Market by Country, 2019 - 2022, USD Thousands
TABLE 26 North America IBS Market by Country, 2023 - 2029, USD Thousands
TABLE 27 North America Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 28 North America Diabetes Market by Country, 2023 - 2029, USD Thousands
TABLE 29 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 30 North America Others Market by Country, 2023 - 2029, USD Thousands
TABLE 31 North America Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2019 - 2022, USD Thousands
TABLE 32 North America Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2023 - 2029, USD Thousands
TABLE 33 US Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 34 US Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 35 US Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 36 US Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 37 Canada Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 38 Canada Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 39 Canada Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 40 Canada Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 41 Mexico Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 42 Mexico Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 43 Mexico Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 44 Mexico Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 45 Rest of North America Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 46 Rest of North America Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 47 Rest of North America Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 48 Rest of North America Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 49 Europe Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 50 Europe Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 51 Europe Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 52 Europe Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 53 Europe C.difficile Market by Country, 2019 - 2022, USD Thousands
TABLE 54 Europe C.difficile Market by Country, 2023 - 2029, USD Thousands
TABLE 55 Europe Crohns Disease Market by Country, 2019 - 2022, USD Thousands
TABLE 56 Europe Crohns Disease Market by Country, 2023 - 2029, USD Thousands
TABLE 57 Europe IBS Market by Country, 2019 - 2022, USD Thousands
TABLE 58 Europe IBS Market by Country, 2023 - 2029, USD Thousands
TABLE 59 Europe Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 60 Europe Diabetes Market by Country, 2023 - 2029, USD Thousands
TABLE 61 Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 62 Europe Others Market by Country, 2023 - 2029, USD Thousands
TABLE 63 Europe Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2019 - 2022, USD Thousands
TABLE 64 Europe Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2023 - 2029, USD Thousands
TABLE 65 Germany Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 66 Germany Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 67 Germany Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 68 Germany Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 69 UK Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 70 UK Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 71 UK Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 72 UK Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 73 France Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 74 France Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 75 France Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 76 France Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 77 Russia Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 78 Russia Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 79 Russia Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 80 Russia Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 81 Spain Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 82 Spain Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 83 Spain Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 84 Spain Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 85 Italy Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 86 Italy Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 87 Italy Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 88 Italy Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 89 Rest of Europe Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 90 Rest of Europe Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 91 Rest of Europe Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 92 Rest of Europe Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 93 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 94 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 95 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 96 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 97 Asia Pacific C.difficile Market by Country, 2019 - 2022, USD Thousands
TABLE 98 Asia Pacific C.difficile Market by Country, 2023 - 2029, USD Thousands
TABLE 99 Asia Pacific Crohns Disease Market by Country, 2019 - 2022, USD Thousands
TABLE 100 Asia Pacific Crohns Disease Market by Country, 2023 - 2029, USD Thousands
TABLE 101 Asia Pacific IBS Market by Country, 2019 - 2022, USD Thousands
TABLE 102 Asia Pacific IBS Market by Country, 2023 - 2029, USD Thousands
TABLE 103 Asia Pacific Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 104 Asia Pacific Diabetes Market by Country, 2023 - 2029, USD Thousands
TABLE 105 Asia Pacific Others Market by Country, 2019 - 2022, USD Thousands
TABLE 106 Asia Pacific Others Market by Country, 2023 - 2029, USD Thousands
TABLE 107 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2019 - 2022, USD Thousands
TABLE 108 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2023 - 2029, USD Thousands
TABLE 109 China Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 110 China Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 111 China Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 112 China Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 113 Japan Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 114 Japan Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 115 Japan Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 116 Japan Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 117 India Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 118 India Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 119 India Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 120 India Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 121 South Korea Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 122 South Korea Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 123 South Korea Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 124 South Korea Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 125 Singapore Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 126 Singapore Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 127 Singapore Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 128 Singapore Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 129 Malaysia Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 130 Malaysia Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 131 Malaysia Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 132 Malaysia Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 133 Rest of Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 134 Rest of Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 135 Rest of Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 136 Rest of Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 137 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 138 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 139 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 140 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 141 LAMEA C.difficile Market by Country, 2019 - 2022, USD Thousands
TABLE 142 LAMEA C.difficile Market by Country, 2023 - 2029, USD Thousands
TABLE 143 LAMEA Crohns Disease Market by Country, 2019 - 2022, USD Thousands
TABLE 144 LAMEA Crohns Disease Market by Country, 2023 - 2029, USD Thousands
TABLE 145 LAMEA IBS Market by Country, 2019 - 2022, USD Thousands
TABLE 146 LAMEA IBS Market by Country, 2023 - 2029, USD Thousands
TABLE 147 LAMEA Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 148 LAMEA Diabetes Market by Country, 2023 - 2029, USD Thousands
TABLE 149 LAMEA Others Market by Country, 2019 - 2022, USD Thousands
TABLE 150 LAMEA Others Market by Country, 2023 - 2029, USD Thousands
TABLE 151 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2019 - 2022, USD Thousands
TABLE 152 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2023 - 2029, USD Thousands
TABLE 153 Brazil Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 154 Brazil Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 155 Brazil Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 156 Brazil Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 157 Argentina Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 158 Argentina Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 159 Argentina Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 160 Argentina Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 161 UAE Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 162 UAE Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 163 UAE Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 164 UAE Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 165 Saudi Arabia Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 166 Saudi Arabia Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 167 Saudi Arabia Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 168 Saudi Arabia Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 169 South Africa Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 170 South Africa Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 171 South Africa Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 172 South Africa Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 173 Nigeria Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 174 Nigeria Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 175 Nigeria Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 176 Nigeria Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 177 Rest of LAMEA Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 178 Rest of LAMEA Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 179 Rest of LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 180 Rest of LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 181 Key Information – Arranta Bio Holdings, LLC
TABLE 182 Key Information – Cerbios-Pharma SA
TABLE 183 Key Information – Biose Industrie
TABLE 184 Key Information – List Biological Laboratories, Inc.
TABLE 185 Key Information – AcuraBio Pty Ltd
TABLE 186 Key Information – Wacker Chemie AG
TABLE 187 Key Information – Quay Pharmaceuticals Ltd
TABLE 188 Key Information – BiomX, Inc.
TABLE 189 Key Information – Lonza Group AG
TABLE 190 Key Information – 4D Pharma Plc
List of Figures
FIG 1 Methodology for the research
FIG 2 Global Live Biotherapeutic Products And Microbiome CDMO Market share by Application, 2022
FIG 3 Global Live Biotherapeutic Products And Microbiome CDMO Market share by Application, 2029
FIG 4 Global Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2029, USD Thousands
FIG 5 Global Live Biotherapeutic Products And Microbiome CDMO Market share by Region, 2022
FIG 6 Global Live Biotherapeutic Products And Microbiome CDMO Market share by Region, 2029
FIG 7 Global Live Biotherapeutic Products And Microbiome CDMO Market by Region, 2019 - 2029, USD Thousands
TABLE 2 Global Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 3 Global Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 4 Global Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 5 Global C.difficile Market by Region, 2019 - 2022, USD Thousands
TABLE 6 Global C.difficile Market by Region, 2023 - 2029, USD Thousands
TABLE 7 Global Crohns Disease Market by Region, 2019 - 2022, USD Thousands
TABLE 8 Global Crohns Disease Market by Region, 2023 - 2029, USD Thousands
TABLE 9 Global IBS Market by Region, 2019 - 2022, USD Thousands
TABLE 10 Global IBS Market by Region, 2023 - 2029, USD Thousands
TABLE 11 Global Diabetes Market by Region, 2019 - 2022, USD Thousands
TABLE 12 Global Diabetes Market by Region, 2023 - 2029, USD Thousands
TABLE 13 Global Others Market by Region, 2019 - 2022, USD Thousands
TABLE 14 Global Others Market by Region, 2023 - 2029, USD Thousands
TABLE 15 Global Live Biotherapeutic Products And Microbiome CDMO Market by Region, 2019 - 2022, USD Thousands
TABLE 16 Global Live Biotherapeutic Products And Microbiome CDMO Market by Region, 2023 - 2029, USD Thousands
TABLE 17 North America Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 18 North America Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 19 North America Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 20 North America Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 21 North America C.difficile Market by Country, 2019 - 2022, USD Thousands
TABLE 22 North America C.difficile Market by Country, 2023 - 2029, USD Thousands
TABLE 23 North America Crohns Disease Market by Country, 2019 - 2022, USD Thousands
TABLE 24 North America Crohns Disease Market by Country, 2023 - 2029, USD Thousands
TABLE 25 North America IBS Market by Country, 2019 - 2022, USD Thousands
TABLE 26 North America IBS Market by Country, 2023 - 2029, USD Thousands
TABLE 27 North America Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 28 North America Diabetes Market by Country, 2023 - 2029, USD Thousands
TABLE 29 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 30 North America Others Market by Country, 2023 - 2029, USD Thousands
TABLE 31 North America Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2019 - 2022, USD Thousands
TABLE 32 North America Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2023 - 2029, USD Thousands
TABLE 33 US Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 34 US Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 35 US Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 36 US Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 37 Canada Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 38 Canada Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 39 Canada Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 40 Canada Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 41 Mexico Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 42 Mexico Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 43 Mexico Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 44 Mexico Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 45 Rest of North America Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 46 Rest of North America Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 47 Rest of North America Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 48 Rest of North America Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 49 Europe Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 50 Europe Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 51 Europe Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 52 Europe Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 53 Europe C.difficile Market by Country, 2019 - 2022, USD Thousands
TABLE 54 Europe C.difficile Market by Country, 2023 - 2029, USD Thousands
TABLE 55 Europe Crohns Disease Market by Country, 2019 - 2022, USD Thousands
TABLE 56 Europe Crohns Disease Market by Country, 2023 - 2029, USD Thousands
TABLE 57 Europe IBS Market by Country, 2019 - 2022, USD Thousands
TABLE 58 Europe IBS Market by Country, 2023 - 2029, USD Thousands
TABLE 59 Europe Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 60 Europe Diabetes Market by Country, 2023 - 2029, USD Thousands
TABLE 61 Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 62 Europe Others Market by Country, 2023 - 2029, USD Thousands
TABLE 63 Europe Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2019 - 2022, USD Thousands
TABLE 64 Europe Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2023 - 2029, USD Thousands
TABLE 65 Germany Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 66 Germany Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 67 Germany Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 68 Germany Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 69 UK Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 70 UK Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 71 UK Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 72 UK Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 73 France Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 74 France Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 75 France Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 76 France Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 77 Russia Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 78 Russia Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 79 Russia Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 80 Russia Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 81 Spain Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 82 Spain Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 83 Spain Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 84 Spain Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 85 Italy Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 86 Italy Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 87 Italy Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 88 Italy Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 89 Rest of Europe Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 90 Rest of Europe Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 91 Rest of Europe Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 92 Rest of Europe Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 93 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 94 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 95 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 96 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 97 Asia Pacific C.difficile Market by Country, 2019 - 2022, USD Thousands
TABLE 98 Asia Pacific C.difficile Market by Country, 2023 - 2029, USD Thousands
TABLE 99 Asia Pacific Crohns Disease Market by Country, 2019 - 2022, USD Thousands
TABLE 100 Asia Pacific Crohns Disease Market by Country, 2023 - 2029, USD Thousands
TABLE 101 Asia Pacific IBS Market by Country, 2019 - 2022, USD Thousands
TABLE 102 Asia Pacific IBS Market by Country, 2023 - 2029, USD Thousands
TABLE 103 Asia Pacific Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 104 Asia Pacific Diabetes Market by Country, 2023 - 2029, USD Thousands
TABLE 105 Asia Pacific Others Market by Country, 2019 - 2022, USD Thousands
TABLE 106 Asia Pacific Others Market by Country, 2023 - 2029, USD Thousands
TABLE 107 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2019 - 2022, USD Thousands
TABLE 108 Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2023 - 2029, USD Thousands
TABLE 109 China Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 110 China Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 111 China Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 112 China Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 113 Japan Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 114 Japan Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 115 Japan Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 116 Japan Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 117 India Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 118 India Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 119 India Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 120 India Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 121 South Korea Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 122 South Korea Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 123 South Korea Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 124 South Korea Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 125 Singapore Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 126 Singapore Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 127 Singapore Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 128 Singapore Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 129 Malaysia Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 130 Malaysia Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 131 Malaysia Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 132 Malaysia Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 133 Rest of Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 134 Rest of Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 135 Rest of Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 136 Rest of Asia Pacific Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 137 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 138 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 139 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 140 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 141 LAMEA C.difficile Market by Country, 2019 - 2022, USD Thousands
TABLE 142 LAMEA C.difficile Market by Country, 2023 - 2029, USD Thousands
TABLE 143 LAMEA Crohns Disease Market by Country, 2019 - 2022, USD Thousands
TABLE 144 LAMEA Crohns Disease Market by Country, 2023 - 2029, USD Thousands
TABLE 145 LAMEA IBS Market by Country, 2019 - 2022, USD Thousands
TABLE 146 LAMEA IBS Market by Country, 2023 - 2029, USD Thousands
TABLE 147 LAMEA Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 148 LAMEA Diabetes Market by Country, 2023 - 2029, USD Thousands
TABLE 149 LAMEA Others Market by Country, 2019 - 2022, USD Thousands
TABLE 150 LAMEA Others Market by Country, 2023 - 2029, USD Thousands
TABLE 151 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2019 - 2022, USD Thousands
TABLE 152 LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Country, 2023 - 2029, USD Thousands
TABLE 153 Brazil Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 154 Brazil Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 155 Brazil Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 156 Brazil Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 157 Argentina Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 158 Argentina Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 159 Argentina Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 160 Argentina Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 161 UAE Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 162 UAE Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 163 UAE Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 164 UAE Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 165 Saudi Arabia Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 166 Saudi Arabia Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 167 Saudi Arabia Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 168 Saudi Arabia Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 169 South Africa Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 170 South Africa Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 171 South Africa Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 172 South Africa Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 173 Nigeria Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 174 Nigeria Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 175 Nigeria Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 176 Nigeria Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 177 Rest of LAMEA Live Biotherapeutic Products And Microbiome CDMO Market, 2019 - 2022, USD Thousands
TABLE 178 Rest of LAMEA Live Biotherapeutic Products And Microbiome CDMO Market, 2023 - 2029, USD Thousands
TABLE 179 Rest of LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2022, USD Thousands
TABLE 180 Rest of LAMEA Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2023 - 2029, USD Thousands
TABLE 181 Key Information – Arranta Bio Holdings, LLC
TABLE 182 Key Information – Cerbios-Pharma SA
TABLE 183 Key Information – Biose Industrie
TABLE 184 Key Information – List Biological Laboratories, Inc.
TABLE 185 Key Information – AcuraBio Pty Ltd
TABLE 186 Key Information – Wacker Chemie AG
TABLE 187 Key Information – Quay Pharmaceuticals Ltd
TABLE 188 Key Information – BiomX, Inc.
TABLE 189 Key Information – Lonza Group AG
TABLE 190 Key Information – 4D Pharma Plc
List of Figures
FIG 1 Methodology for the research
FIG 2 Global Live Biotherapeutic Products And Microbiome CDMO Market share by Application, 2022
FIG 3 Global Live Biotherapeutic Products And Microbiome CDMO Market share by Application, 2029
FIG 4 Global Live Biotherapeutic Products And Microbiome CDMO Market by Application, 2019 - 2029, USD Thousands
FIG 5 Global Live Biotherapeutic Products And Microbiome CDMO Market share by Region, 2022
FIG 6 Global Live Biotherapeutic Products And Microbiome CDMO Market share by Region, 2029
FIG 7 Global Live Biotherapeutic Products And Microbiome CDMO Market by Region, 2019 - 2029, USD Thousands